Baker Brothers Advisors - ALDEYRA THERAPEUTICS INC ownership

ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of ALDEYRA THERAPEUTICS INC
ValueSharesWeighting
Q4 2016$760,000
-31.5%
142,0000.0%0.01%
-30.0%
Q3 2016$1,110,000
+37.4%
142,0000.0%0.01%
+25.0%
Q2 2016$808,000
+35.8%
142,0000.0%0.01%
+33.3%
Q1 2016$595,000
-38.2%
142,0000.0%0.01%
-25.0%
Q4 2015$963,000
+16.3%
142,0000.0%0.01%0.0%
Q3 2015$828,000
-24.9%
142,0000.0%0.01%
-20.0%
Q2 2015$1,102,000
-23.8%
142,0000.0%0.01%
-16.7%
Q1 2015$1,446,000142,0000.01%
Other shareholders
ALDEYRA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Prosight Management, LP 473,446$5,625,0004.61%
Knoll Capital Management, LLC 569,405$6,765,0004.41%
SILVERARC CAPITAL MANAGEMENT, LLC 321,879$3,824,0002.09%
First Light Asset Management, LLC 2,624,001$31,173,0002.07%
Mesirow Financial Investment Management, Inc. 63,634$756,0002.06%
Ghost Tree Capital, LLC 650,000$7,722,0001.82%
Altium Capital Management LP 548,225$6,513,0001.81%
Perceptive Advisors 8,703,879$103,402,0001.31%
Affinity Asset Advisors, LLC 300,000$3,564,0001.21%
Avidity Partners Management LP 2,552,000$30,318,0000.84%
View complete list of ALDEYRA THERAPEUTICS INC shareholders